Share 'PPMD’s Duchenne Drug Development Roundtable: Bringing Industry Together to Accelerate Research'
Better. Faster. Now.
How do we apply the ‘regulatory learnings’ of the past 18 months back into our robust Duchenne pipeline to ensure as many effective therapies yield from our pipeline as possible?
Under the leadership of PPMD's Duchenne Drug Development Roundtable (DDDR), our community is determined to figure that out. Today is the first of a three-meeting series to address challenges and o…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this